Filing Details

Accession Number:
0000884731-16-000109
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-05 16:17:59
Reporting Period:
2016-10-03
Filing Date:
2016-10-05
Accepted Time:
2016-10-05 16:17:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1461612 M Daniel Bollag C/O Ariad Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge MA 02139
Sr. Vp, Reg. Affairs & Quality No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-10-03 47,384 $13.46 129,404 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares were sold pursuant to a Rule 10b5-1 trading plan dated June 15, 2016
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.33 to $13.65 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer,or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.